太极集团：股东重庆太极药用动植物资源公司拟吸收合并希兰生物

Group 1 - The core point of the article is that Taiji Group's shareholder, Chongqing Taiji Medicinal Plant Resources Development Co., Ltd., plans to absorb and merge with Chongqing Fuling Xilan Biotechnology Co., Ltd. [1] - Upon completion of the merger, Xilan Biotechnology will be legally deregistered, and the number of shares held by the Medicinal Plant Resources Company will increase from 367,300 shares to 12,262,600 shares, representing 2.224% of the company's total share capital [1]